These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16367990)

  • 1. De Jong, Krabbe, Laheij & Van Cauter refuted: evidence-based non-effectiveness can hardly be patient-friendly.
    de Jong CJ; Laheij RJ; Krabbe PF; van Cauter Victory RM
    Addiction; 2005 Dec; 100(12):1884-5. PubMed ID: 16367990
    [No Abstract]   [Full Text] [Related]  

  • 2. General anaesthesia is patient-friendly in opioid antagonist detoxification treatment.
    De Jong CJ
    Addiction; 2005 Nov; 100(11):1742-4. PubMed ID: 16277635
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid opioid detoxification.
    Gooberman LL
    JAMA; 1998 Jun; 279(23):1871; author reply 1872. PubMed ID: 9634250
    [No Abstract]   [Full Text] [Related]  

  • 4. Do antagonists have a role in the treatment of opioid dependence?
    Jaffe JH
    Addiction; 2006 Apr; 101(4):468-9. PubMed ID: 16548923
    [No Abstract]   [Full Text] [Related]  

  • 5. Naltrexone-mediated opiate detoxification: a matter of terminology!
    Johnson TS; Carr M
    Addict Biol; 2003 Sep; 8(3):267-9. PubMed ID: 13129827
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultra-rapid opioid detoxification: current status and controversies.
    Singh J; Basu D
    J Postgrad Med; 2004; 50(3):227-32. PubMed ID: 15377814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experts debate merits of 1-day opiate detoxification under anesthesia.
    Stephenson J
    JAMA; 1997 Feb; 277(5):363-4. PubMed ID: 9010155
    [No Abstract]   [Full Text] [Related]  

  • 9. Reentry using naltrexone: one anesthesia department's experience.
    Hudson S
    AANA J; 1998 Aug; 66(4):360-4. PubMed ID: 9830862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications of accelerated opioid detoxification].
    Zemtsovskiĭ MIu; Kipriianov VS; Tros'ko OU; Brazhnikov AV; Strashnov VI
    Anesteziol Reanimatol; 2005; (3):11-5. PubMed ID: 16076037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.
    Johansson BA; Berglund M; Lindgren A
    Addiction; 2006 Apr; 101(4):491-503. PubMed ID: 16548929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unethical promotion of rapid opiate detoxification under anaesthesia (RODA).
    Brewer C; Williams J; Carreño Rendueles E; Garcia JB
    Lancet; 1998 Jan; 351(9097):218. PubMed ID: 9449900
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'.
    Brewer C
    Drug Alcohol Rev; 2008 Jul; 27(4):447-8; author reply 448-9. PubMed ID: 18584398
    [No Abstract]   [Full Text] [Related]  

  • 15. Unintentional rapid opioid detoxification: case report.
    Singh SM; Sharma B
    Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
    Degenhardt L; Gibson A; Mattick RP; Hall W
    Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid opioid detoxification under anaesthesia.
    Justins D
    Hosp Med; 1998 Mar; 59(3):180. PubMed ID: 9722340
    [No Abstract]   [Full Text] [Related]  

  • 19. Vivitrex (Alkermes/Cephalon).
    Heading CE
    Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
    Reece AS
    J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.